Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Conference News EuroPCR 2024

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

Michael O'Riordan

May 28, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

Presentation TCT 2023

A Randomized Clinical Trial of a Novel Triple Drug Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus: Six-Month Clinical and Imaging Results of the DESyne BDS Plus Study

Presenter: Stefan Verheye

October 25, 2023

Presentation TCT 2023

DESyne BDS Plus Stent

Presenter: Stefan Verheye

October 24, 2023

Presentation TCT 2023

The Coronary Sinus Reducer

Presenter: Stefan Verheye

October 24, 2023

Presentation TCT 2023

Lithotrispy: A novel approach to calcium fragmentation

Presenter: Stefan Verheye

October 24, 2023

News Industry News

Robocath successfully completes first robotic coronary angioplasties in Belgium

May 04, 2021

News Conference News EuroPCR 2020

DynamX Bioadaptor Provides Promising Preliminary Results for De Novo Coronary Lesions

Todd Neale

June 30, 2020

Presentation TCT 2019

Sirolimus-Coated Balloon Therapy: State of Development

Presenter: Stefan Verheye

September 28, 2019

Presentation TCT 2019

DynamX Bioadaptor, an Innovative Device That Adapts to Patients’ Physiology for PCI Treatment of Coronary Artery Disease: 12-Month Clinical and Imaging Results

Presenter: Stefan Verheye

September 27, 2019

Presentation TCT 2019

TCT 45: Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting - First Cohort Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry

Presenter: Stefan Verheye

September 25, 2019

News Conference News EuroPCR 2018

New Bioresorbable Scaffold, Magmaris, Delivers Positive Early Outcomes

Michael O'Riordan

May 25, 2018

Presentation EuroPCR 2018

Safety and performance of the resorbable magnesium scaffold, Magmaris in a real world setting - First 200 subjects at 12-month follow-up of the BIOSOLVE-IV registry

Presenter: Stefan Verheye

May 25, 2018

Presentation TCT 2017

Desolve Nx, Cx, and Amity: A Family of Progressively Thinner-Strut PLLA-Based BRS With Novel Properties

Presenter: Bernard R. Chevalier, Corrado Tamburino, Stefan Verheye

October 31, 2017

Presentation TCT 2017

TCT 16: Prospective, Multicenter Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold - Imaging Outcomes and Five-Year Clinical and Imaging Results

Presenter: Stephan Achenbach, Jacques J. Koolen, Stefan Verheye

October 31, 2017

Presentation TCT 2012

Dedicated Bifurcation Stents: Biosensors Program Update

Presenter: Stefan Verheye

October 22, 2012

Presentation TCT 2012

Dedicated Bifurcation Stents: STENTYS Program Update

Presenter: Stefan Verheye

October 22, 2012

Advertisement

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

A Randomized Clinical Trial of a Novel Triple Drug Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus: Six-Month Clinical and Imaging Results of the DESyne BDS Plus Study

DESyne BDS Plus Stent

The Coronary Sinus Reducer

Lithotrispy: A novel approach to calcium fragmentation

Robocath successfully completes first robotic coronary angioplasties in Belgium

DynamX Bioadaptor Provides Promising Preliminary Results for De Novo Coronary Lesions

Sirolimus-Coated Balloon Therapy: State of Development

DynamX Bioadaptor, an Innovative Device That Adapts to Patients’ Physiology for PCI Treatment of Coronary Artery Disease: 12-Month Clinical and Imaging Results

TCT 45: Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting - First Cohort Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry

New Bioresorbable Scaffold, Magmaris, Delivers Positive Early Outcomes

Safety and performance of the resorbable magnesium scaffold, Magmaris in a real world setting - First 200 subjects at 12-month follow-up of the BIOSOLVE-IV registry

Desolve Nx, Cx, and Amity: A Family of Progressively Thinner-Strut PLLA-Based BRS With Novel Properties

TCT 16: Prospective, Multicenter Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold - Imaging Outcomes and Five-Year Clinical and Imaging Results

Dedicated Bifurcation Stents: Biosensors Program Update

Dedicated Bifurcation Stents: STENTYS Program Update

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content